AGP Picks
View all

California Health Watch
Provided by AGP

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
May 18, 2026

Certara to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
May 18, 2026

Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 18, 2026

Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference
May 18, 2026

Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference

Indeterminate GlobeNewswire
Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland
May 18, 2026

Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland

Indeterminate GlobeNewswire
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 18, 2026

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire
DeGen Medical Expands Patient-Specific Spine Platform
May 18, 2026

DeGen Medical Expands Patient-Specific Spine Platform

Indeterminate GlobeNewswire
Memopezil Claims Evaluated (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
May 18, 2026

Memopezil Claims Evaluated (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks

Indeterminate GlobeNewswire
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD  
May 18, 2026

Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD  

Indeterminate GlobeNewswire
Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT
May 18, 2026

Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT

Indeterminate GlobeNewswire
Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
May 18, 2026

Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment

Indeterminate GlobeNewswire
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
May 18, 2026

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

Indeterminate GlobeNewswire
NADP: provider, patient benefits rose; dental plan enrollment fell in 2024
May 18, 2026

NADP: provider, patient benefits rose; dental plan enrollment fell in 2024

Indeterminate GlobeNewswire
Joyce University of Nursing and Health Sciences Earns Maximum 10-Year CCNE Accreditation for MSN Program
May 18, 2026

Joyce University of Nursing and Health Sciences Earns Maximum 10-Year CCNE Accreditation for MSN Program

Indeterminate GlobeNewswire
Letter to Shareholders from CEO Dr. Ryan Saadi
May 18, 2026

Letter to Shareholders from CEO Dr. Ryan Saadi

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.